Press Release

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences

May 24, 2019 at 4:01 PM EDT

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--May 24, 2019-- Five Prime Therapeutics, Inc.(NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics today announced that Aron Knickerbocker, Chief Executive Officer, is scheduled to present at the following two investor conferences:

  • The Jefferies Healthcare Conference, on Thursday, June 6th at 9:30am ET / 6:30am PT
  • The 40th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 12th at 1:00pm ET / 10:00am PT

The presentations will be webcast and may be accessed at the “Events & Presentations” section of the Company’s website at: http://investor.fiveprime.com/events.cfm. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.

About Five Prime

Five Prime Therapeutics, Inc. discovers and develops innovative protein therapeutics to improve the lives of patients with serious diseases. Five Prime’s product candidates have innovative mechanisms of action and address patient populations in need of better therapies. The company focuses on researching and developing immuno-oncology and targeted cancer therapies paired with companion diagnostics to identify patients who are most likely to benefit from treatment with Five Prime’s product candidates. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. For more information, please visit www.fiveprime.com or follow us on LinkedInTwitter and Facebook.

Source: Five Prime Therapeutics, Inc.

Source: Five Prime Therapeutics, Inc.

Media and Investor Contact
Martin Forrest
VP, Investor Relations & Corporate Communications
Five Prime Therapeutics, Inc.
415-365-5625
martin.forrest@fiveprime.com